Hap Trading, LLC Gsk PLC Put Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $2.3 Million - $2.61 Million	-54,700 Reduced 73.82%	19,400 $29,000
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $1.7 Million - $2.01 Million	42,200 Added 132.29%	74,100 $38,000
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $81,648 - $95,151	-2,100 Reduced 6.18%	31,900 $26,000
Q3 2021 Nov 10, 2021	SELL	$38.79 - $43.16 $259,893 - $289,172	-6,700 Reduced 16.46%	34,000 $85,000
Q2 2021 Aug 11, 2021	SELL	$36.52 - $41.46 $266,596 - $302,658	-7,300 Reduced 15.21%	40,700 $64,000
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $287,868 - $336,084	8,400 Added 21.21%	48,000 $134,000
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $967,588 - $1.13 Million	28,400 Added 253.57%	39,600 $135,000
Q2 2020 Aug 10, 2020	SELL	$37.87 - $43.58 $462,013 - $531,676	-12,200 Reduced 52.14%	11,200 $35,000
Q1 2020 May 08, 2020	BUY	$32.47 - $48.83 $178,585 - $268,565	5,500 Added 30.73%	23,400 $169,000
Q3 2019 Nov 12, 2019	BUY	$40.46 - $43.52 $32,368 - $34,816	800 Added 4.68%	17,900 $10,000
Q1 2019 May 10, 2019	BUY	$38.57 - $42.69 $181,279 - $200,643	4,700 Added 37.9%	17,100 $12,000
Q4 2018 Feb 12, 2019	SELL	$37.8 - $42.69 $374,220 - $422,631	-9,900 Reduced 44.39%	12,400 $26,000
Q3 2018 Nov 09, 2018	BUY	$39.75 - $42.69 $488,925 - $525,087	12,300 Added 123.0%	22,300 $38,000
Q1 2018 May 11, 2018	SELL	$36.18 - $40.15 $1.26 Million - $1.4 Million	-34,900 Reduced 77.73%	10,000 $2,000
Q4 2017 Feb 09, 2018	BUY	$35.34 - $41.9 $91,884 - $108,940	2,600 Added 6.15%	44,900 $22,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $1.67 Million - $1.76 Million	42,300	42,300 $5,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account